Recombinant approaches to IgG-like bispecific antibodies
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 26 (6) , 649-658
- https://doi.org/10.1111/j.1745-7254.2005.00119.x
Abstract
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciencesKeywords
This publication has 53 references indexed in Scilit:
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexCancer Cell, 2004
- Stability engineering of antibody single-chain Fv fragmentsJournal of Molecular Biology, 2001
- Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokineticsJournal of Molecular Biology, 1999
- Novel tetravalent and bispecific IgG‐like antibody molecules combining single‐chain diabodies with the immunoglobulin γ1 Fc or CH3 regionFEBS Letters, 1999
- Stable heterodimers from remodeling the domain interface of a homodimer using a phage display libraryJournal of Molecular Biology, 1997
- Remodeling domain interfaces to enhance heterodimer formationProtein Science, 1997
- ‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerizationProtein Engineering, Design and Selection, 1996
- High Level Secretion of a Humanized Bispecific Diabody from Escherichia coliNature Biotechnology, 1996
- X-ray Structures of the Antigen-binding Domains from Three Variants of Humanized anti-p185HER2 Antibody 4D5 and Comparison with Molecular ModelingJournal of Molecular Biology, 1993